ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies
Alzheimer's disease (AD) is the most common cause of dementia worldwide, and its
prevalence is rapidly increasing due to extended lifespans. Among the increasing number of …
prevalence is rapidly increasing due to extended lifespans. Among the increasing number of …
APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases
R Fernández-Calle, SC Konings… - Molecular …, 2022 - Springer
ApoE is the major lipid and cholesterol carrier in the CNS. There are three major human
polymorphisms, apoE2, apoE3, and apoE4, and the genetic expression of APOE4 is one of …
polymorphisms, apoE2, apoE3, and apoE4, and the genetic expression of APOE4 is one of …
Brain lipidomics: From functional landscape to clinical significance
JH Yoon, Y Seo, YS Jo, S Lee, E Cho… - Science …, 2022 - science.org
Lipids are crucial components of cellular function owing to their role in membrane formation,
intercellular signaling, energy storage, and homeostasis maintenance. In the brain, lipid …
intercellular signaling, energy storage, and homeostasis maintenance. In the brain, lipid …
Mitophagy in Alzheimer's disease: Molecular defects and therapeutic approaches
Mitochondrial dysfunctions are central players in Alzheimer's disease (AD). In addition,
impairments in mitophagy, the process of selective mitochondrial degradation by autophagy …
impairments in mitophagy, the process of selective mitochondrial degradation by autophagy …
APOE2: protective mechanism and therapeutic implications for Alzheimer's disease
Investigations of apolipoprotein E (APOE) gene, the major genetic risk modifier for
Alzheimer's disease (AD), have yielded significant insights into the pathogenic mechanism …
Alzheimer's disease (AD), have yielded significant insights into the pathogenic mechanism …
Insights from multi-omics integration in complex disease primary tissues
Genome-wide association studies (GWAS) have provided insights into the genetic basis of
complex diseases. In the next step, integrative multi-omics approaches can characterize …
complex diseases. In the next step, integrative multi-omics approaches can characterize …
Cell type-specific roles of APOE4 in Alzheimer disease
The ɛ4 allele of the apolipoprotein E gene (APOE), which translates to the APOE4 isoform,
is the strongest genetic risk factor for late-onset Alzheimer disease (AD). Within the CNS …
is the strongest genetic risk factor for late-onset Alzheimer disease (AD). Within the CNS …
APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge
S Lee, NA Devanney, LR Golden, CT Smith… - Cell reports, 2023 - cell.com
The E4 allele of Apolipoprotein E (APOE) is associated with both metabolic dysfunction and
a heightened pro-inflammatory response: two findings that may be intrinsically linked …
a heightened pro-inflammatory response: two findings that may be intrinsically linked …
Phospholipids of APOE lipoproteins activate microglia in an isoform-specific manner in preclinical models of Alzheimer's disease
APOE and Trem2 are major genetic risk factors for Alzheimer's disease (AD), but how they
affect microglia response to Aβ remains unclear. Here we report an APOE isoform-specific …
affect microglia response to Aβ remains unclear. Here we report an APOE isoform-specific …
APOE3-Jacksonville (V236E) variant reduces self-aggregation and risk of dementia
Apolipoprotein E (APOE) genetic variants have been shown to modify Alzheimer's disease
(AD) risk. We previously identified an APOE3 variant (APOE 3-V236E), named APOE3 …
(AD) risk. We previously identified an APOE3 variant (APOE 3-V236E), named APOE3 …